USEUROPEAFRICAASIA 中文雙語Fran?ais
    Lifestyle
    Home / Lifestyle / Health

    New technique may help predict cancer patient survival

    English.news.cn | Updated: 2013-12-06 11:14

    U.S. researchers said Wednesday they have found a potential way to predict survival in ovarian cancer patients by counting the number of tumor-attacking immune cells that have migrated into the tumor in an effort to eradicate it.

    Researchers at Fred Hutchinson Cancer Research Center said that their method is able to count these cells known as tumor- infiltrating T lymphocytes, or TILs, "reliably, quickly and cheaply" in patients with early stage and advanced ovarian cancer.

    Such technology, a DNA-amplification technique, has the potential to predict treatment response, cancer recurrence and disease-free survival earlier and more effectively than any current method, the researchers reported in the U.S. journal Science Translational Medicine.

    "Our experiments demonstrate an association between higher TIL counts and improved survival among women with ovarian cancer, and are consistent with prior observations that the immune response against ovarian cancer is a meaningful and independent prognostic factor," lead researcher Jason Bielas, an associate member of the Human Biology and Public Health Sciences divisions at the center, said in a statement.

    The novel technique, called QuanTILfy, was tested on tumor samples from 30 ovarian cancer patients with known survival outcomes ranging from one to 122 months.

    The researchers looked at the levels of TILs in their tumors and compared those levels to the women's survival.

    They found that higher TIL numbers correlated with better survival. For example, the percentage of TILs was approximately three times higher on average for patients with a survival rate of more than five years as compared to patients with a survival rate of less than two years.

    "Now that we have the sensitivity and ability to reproducibly count TILs in tumors, we may be able to stratify and more effectively treat patients based on tumor TIL count," Bielas said.

    Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
    License for publishing multimedia online 0108263

    Registration Number: 130349
    FOLLOW US
    日韩久久久久中文字幕人妻| 国产亚洲精久久久久久无码| 久久亚洲AV成人出白浆无码国产 | 精品久久久久久中文字幕| 无码aⅴ精品一区二区三区浪潮| 久久久中文字幕| 黑人无码精品又粗又大又长 | 中文字字幕在线中文无码| 中文字幕人妻无码系列第三区| 秋霞鲁丝片Av无码少妇| 成人无码WWW免费视频| 日本中文字幕在线2020| 亚洲国产精品无码久久青草| 日韩av无码久久精品免费| 亚洲精品无码精品mV在线观看| 亚洲国产综合精品中文字幕 | 最近高清中文字幕无吗免费看| 十八禁无码免费网站| 最好看的最新高清中文视频| 波多野结衣中文在线| 少妇中文无码高清| 国产啪亚洲国产精品无码| 无码少妇一区二区性色AV| 亚洲伊人久久综合中文成人网 | 伊人久久无码中文字幕| 最近高清中文字幕免费| 中文字幕精品亚洲无线码一区| 国产无码一区二区在线| 91无码人妻精品一区二区三区L| 无码国产色欲XXXXX视频| 一区二区三区无码视频免费福利| 一级片无码中文字幕乱伦| 中文字幕在线免费观看| 中文字幕亚洲精品资源网| 99高清中文字幕在线 | 亚洲韩国—中文字幕| 久久精品aⅴ无码中文字字幕不卡 久久精品aⅴ无码中文字字幕重口 | 中文字幕在线看视频一区二区三区| 久久精品中文字幕久久| 日韩乱码人妻无码中文字幕视频 | 中文字幕无码不卡在线|